Private Wealth Management Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1K Hold
426
﹤0.01% 464
2026
Q1
$11.8K Hold
426
﹤0.01% 479
2025
Q4
$9.24K Hold
426
﹤0.01% 532
2025
Q3
$6.45K Hold
426
﹤0.01% 692
2025
Q2
$4.8K Sell
426
-11
-3% -$119 ﹤0.01% 769
2025
Q1
$4.41K Buy
+437
New +$4.73K ﹤0.01% 781

Other funds holding ROIV

Private Wealth Management Group's ROIV Position: Q2 2026 in Review

Private Wealth Management Group held its Roivant Sciences (ROIV) position steady in Q2 2026 at 426 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Private Wealth Management Group first reported a position in ROIV in Q1 2025 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Private Wealth Management Group held 426 shares of Roivant Sciences worth $15.1K as of Q2 2026.
  • Private Wealth Management Group left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #464 holding.
  • Private Wealth Management Group first reported a position in Roivant Sciences in Q1 2025 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.